United States · FDA National Drug Code directory
ZELAPAR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0187-0453_ff911cbd-70ba-4034-8831-a81676d7811c
- Product NDC
- 0187-0453
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- SELEGILINE HYDROCHLORIDE
- Labeler
- Bausch Health US, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20060614 / 20280731
Source-listed ingredients
- SELEGILINE HYDROCHLORIDE — 1.25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 POUCH in 1 CARTON (0187-0453-02) / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCH · 0187-0453-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →